11th Annual PEGS Europe
地点:葡萄牙,里斯本,Lisbon Congress Center
Bispecifics ( 双特异性抗体单元 )

赞助商    |   赞助商名单


PEGS Europe是欧洲最大型网罗蛋白质工程和抗体工程各面向的活动。本高峰会于2018年在葡萄牙里斯本举行,齐聚了来自全球36个国家1,100多位代表(其中70%为制药产业及生物科技产业相关组织代表) ,一同讨论该领域的最新发展。2019的会议将更注重质量更为充实。

  • 约有1,300位出席者
  • 约有260位演讲者
  • 25组问题解决团体讨论
  • 约有250件海报发表
  • 100家以上的主要企业与团体以赞助商或展商身分参加
  • 以建立人脉为目的的各项活动
  • 保证展示会与海报发表的参觀时间



> 短期课程

Cambridge Healthtech Institute (CHI)培训讲座广泛网罗实际案例研讨、所遇到问题和解决对策、各项议题根基的基础科学知识。讲座由经验丰富的专家主持,透过正式讲授、互动讨论和各种活动,可吸收诸多知识最大化您的学习体验。在培训讲座中可聆听制药产业各面向的深入解说,这对于来自产业界及学术界组织经验较少的研究人员、辅助人员而言相当有助益。

> 培训讲座


Bahija Jallal, PhD, CEO and Director of the Board, Immunocore
James A. Wells, PhD, Professor, Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco


“The best biologics technology meeting in Europe: a must-attend conference for novel biologics.”
- Rakesh D., PhD, VP, MedImmune

“I was very much impressed by the quality of the event, the depth and breadth of the presentations, as well as the scientific discussions and excitement. This is the event to participate and enjoy.”
- Yan Q., PhD, Senior Principal Scientist, Rinat Pfizer

"The best protein engineering conference in Europe! The breadth of topics was truly impressive, with excellent talks, discussions as well as networking on everything from details of sophisticated protein engineering to updates on recent clinical studies of new biologics. A must go!”
- John L., PhD, Associate Professor, KTH Royal Institute of Technology

“Once more PEGS Europe was a great event, packed with know-how knowledge, and networking at its best.”
- Philipp M., PhD, Principal Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG

“You really have the ability to put together diverse and interesting speakers together with real data – not just sales pitch data! I hope all enjoyed as much as I did.”
- Denise F., MD, PhD, Director, Massachusetts General Hospital, and Associate Professor, Harvard Medical School

“PEGS Europe is the place to be for everyone working on antibodies and next generation biologics.”
- Martin B., PhD, Head, Biochemical and Analytical Research, Roche

> 其他与会者感想

Choose your language